autologous stem cell transplant clinical trials

Elotuzumab in Combination With Carfilzomib, Lenalidomide and Dexamethasone (E-KRd) Versus KRd in MM

This study looks at a new drug combination, E-KRd, for people just diagnosed with multiple myeloma. It adds a drug called Elotuzumab to a standard treatment (KRd) to see if it works better at controlling the cancer and keeping it away for longer.